Carnegie financial adviser to Serendipity Partners in the sale of Evondos Oy to Verdane
On the 7th of May it was announced that Verdane, the specialist Northern European growth equity investor, has acquired Evondos, the Finland-based Nordic leader in automated medicine dispensing services for elderly home care clients.
Evondos’ automated medicine dispensing service for independent living and improved medical adherence have made Evondos the partner of choice for over 200 regions and municipalities
Evondos’ vision is to become the global leader in the automated medicine dispensing market. Based in Salo, Finland, Evondos is the Nordic market leader in developing automated medicine dispensing solutions and services. The superior reliability of its dispenser robot, which is capable of reading all multidose sachets in the Nordic market, has made Evondos the leader in its field. Founded in 2007, Evondos today has offices spread across Finland, Norway, Sweden and Denmark supporting over 200 municipal clients, safely distributing over 4 million doses to date.
Evondos is the leading provider of automated medicine dispensing services in the Nordics. Evondos’ unique service provides significant quality and cost benefits for professional home care organizations. The service enables people in need of medical treatment to get the right medicine at the right time and in the right dosage automatically, which improves patient safety, medical adherence and supports independent life at home. The service is based on advanced technology and consists of an automatic medicine dispensing robot installed in private homes, with a cloud-based control system and service elements. Evondos currently employs 85 people in Finland, Sweden, Norway and Denmark. Evondos’ headquarters and production facilities are located in Salo, Finland.
Carnegie acted as financial adviser in connection with the transaction.